Procyon Advisors Buys Stake in IDEXX Laboratories

Investment firm adds 2,905 shares of veterinary diagnostics company

Mar. 23, 2026 at 9:38am

Got story updates? Submit your updates here. ›

Procyon Advisors LLC, an investment management firm, purchased a new stake of 2,905 shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) during the fourth quarter. The shares were valued at approximately $1,966,000.

Why it matters

IDEXX Laboratories is a leading provider of diagnostic products and services for the animal health, water testing, and food safety markets. The purchase by Procyon Advisors suggests the firm sees growth potential in IDEXX's business and stock.

The details

According to a recent SEC filing, Procyon Advisors bought the 2,905 shares of IDEXX Laboratories in the fourth quarter of 2025. This represents a new stake in the company for the investment firm.

  • Procyon Advisors purchased the IDEXX shares in the fourth quarter of 2025.

The players

Procyon Advisors LLC

An investment management firm that purchased a new stake in IDEXX Laboratories.

IDEXX Laboratories, Inc.

A global developer, manufacturer and provider of diagnostic products and services primarily for the animal health, water testing and food safety markets.

Got photos? Submit your photos here. ›

The takeaway

The investment by Procyon Advisors in IDEXX Laboratories reflects the firm's confidence in the growth potential of the veterinary diagnostics company. As IDEXX continues to expand its product offerings and global footprint, investors will be watching to see if other institutional investors follow Procyon's lead.